• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.05% Nasdaq Up 0.17%

    BioMarin Pharmaceutical Inc. (BMRN)

    -NasdaqGS
    87.51 Down 1.78(1.99%) Feb 24, 4:00PM EST
    |After Hours : 86.94 Down 0.57 (0.65%) Feb 24, 7:54PM EST
    Prev Close:89.29
    Open:87.99
    Bid:85.01 x 1000
    Ask:87.50 x 100
    1y Target Est:113.11
    Beta:2.0534
    Earnings Date:Apr 26 - May 1 (Est.)
    Day's Range:85.88 - 88.82
    52wk Range:73.45 - 102.49
    Volume:2,390,386
    Avg Vol (3m):1,166,550
    Market Cap:15.05B
    P/E (ttm):N/A
    EPS (ttm):-3.81
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    BMRNDown 1.99%15.05B
    FOLDDown 1.49%850.44M
    1 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):13.80
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-17) :-1.02
    Quarterly EPS Est (Mar-17) :-0.33
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):-3.43

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback